These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12174931)

  • 1. Linkage of elevated ets-2 expression to hepatocarcinogenesis.
    Ito Y; Miyoshi E; Takeda T; Nagano H; Sakon M; Noda K; Tsujimoto M; Monden M; Matsuura N
    Anticancer Res; 2002; 22(4):2385-9. PubMed ID: 12174931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and possible role of ets-1 in hepatocellular carcinoma.
    Ito Y; Miyoshi E; Takeda T; Sakon M; Noda K; Tsujimoto M; Monden M; Taniguchi N; Matsuura N
    Am J Clin Pathol; 2000 Nov; 114(5):719-25. PubMed ID: 11068545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
    Ozaki I; Mizuta T; Zhao G; Yotsumoto H; Hara T; Kajihara S; Hisatomi A; Sakai T; Yamamoto K
    Cancer Res; 2000 Nov; 60(22):6519-25. PubMed ID: 11103822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
    Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
    Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.
    Ito Y; Matsuura N; Sakon M; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Monden M
    Br J Cancer; 1999 Oct; 81(4):747-51. PubMed ID: 10574266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ets-1 and ets-2 in colonic neoplasms.
    Ito Y; Takeda T; Okada M; Matsuura N
    Anticancer Res; 2002; 22(3):1581-4. PubMed ID: 12168840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
    Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
    Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival.
    Schmitt-Gräff A; Ertelt V; Allgaier HP; Koelble K; Olschewski M; Nitschke R; Bochaton-Piallat ML; Gabbiani G; Blum HE
    Hepatology; 2003 Aug; 38(2):470-80. PubMed ID: 12883492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets-2 overexpression contributes to progression of pancreatic adenocarcinoma.
    Ito Y; Miyoshi E; Takeda T; Sakon M; Ihara S; Tsujimoto M; Matsuura N
    Oncol Rep; 2002; 9(4):853-7. PubMed ID: 12066221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.
    Ito Y; Takeda T; Sakon M; Tsujimoto M; Higashiyama S; Noda K; Miyoshi E; Monden M; Matsuura N
    Br J Cancer; 2001 May; 84(10):1377-83. PubMed ID: 11355950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis.
    Soni S; Pande P; Shukla NK; Ralhan R
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):336-42. PubMed ID: 12073053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
    Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
    Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.
    Matsumoto H; Nagao M; Ogawa S; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Fujii H; Koyama F; Mukogawa T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1333-41. PubMed ID: 12820391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.